NEMO nuances NF-κB

Circulation Research

Volumn 106, Issue 1, 2010, Pages 10-12

  Nemchenko, Andriy ^a   Hill, Joseph A ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B; I KAPPA B ALPHA; I KAPPA B KINASE GAMMA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN P50; PROTEIN P52;

CELL SURVIVAL; EDITORIAL; HEART FAILURE; HEART MUSCLE CELL; HEART PROTECTION; HEART VENTRICLE REMODELING; HUMAN; NONHUMAN; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

ANIMALS; ANTIOXIDANTS; CARDIOMYOPATHY, DILATED; CELLS, CULTURED; GENE DELETION; HEART FAILURE; HUMANS; I-KAPPA B KINASE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; MYOCYTES, CARDIAC; NF-KAPPA B; OXIDATIVE STRESS; SIGNAL TRANSDUCTION;

EID: 74049136179     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.109.211185     Document Type: Editorial

References (33)

1. Hill JA, Olson EN. Cardiac plasticity. N Engl J Med. 2008;358: 1370-1380.
2. Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, Flegal K, Ford E, Furie K, Go A, Greenlund K, Haase N, Hailpern S, Ho M, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott M, Meigs J, Mozaffarian D, Nichol G, O'Donnell C, Roger V, Rosamond W, Sacco R, Sorlie P, Stafford R, Steinberger J, Thorn T, Wasserthiel-Smoller S, Wong N, Wylie-Rosett J, Hong Y. Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2009;119:480-486.
3. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990;322:1561-1566.
4. Frey N, Katus HA, Olson EN, Hill JA. Hypertrophy of the heart: a new therapeutic target? Circulation. 2004;109:1580-1589.
5. Jones WK, Brown M, Wilhide M, He SW, Ren XP. NF-kappa B in cardiovascular disease-diverse and specific effects of a "general" transcription factor? Cardiovasc Toxicol. 2005;5:183-201.
6. Hall G, Hasday JD, Rogers TB. Regulating the regulator: NF-kappa B signaling in heart. J Mol Cell Cardiol. 2006;41:580-591.
7. Beg AA, Sha WC, Bronson RT, Ghosh S, Baltimore D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature. 1995;376:167-170.
8. Li Q, Van Antwerp D, Mercurio F, Lee KF, Verma IM. Severe liver degeneration in mice lacking the IkappaB kinase 2 gene. Science. 1999; 284:321-325.
9. Tanaka M, Fuentes ME, Yamaguchi K, Durnin MH, Dalrymple SA, Hardy KL, Goeddel DV. Embryonic lethality, liver degeneration, and impaired NF-kappa B activation in IKK-beta-deficient mice. Immunity. 1999;10:421-429.
10. Grundstrom S, Anderson P, Scheipers P, Sundstedt A. Bcl-3 and NF kappa B p50-p50 homodimers act as transcriptional repressors in tolerant CD4( + ) T cells. J Biol Chem. 2004;279:8460-8468.
11. Guan HC, Hou SH, Ricciardi RP. DNA binding of repressor nuclear factor-kappa B p50/p50 depends on phosphorylation of Ser(337) by the protein kinase A catalytic subunit. J Biol Chem. 2005;280:9957-9962.
12. Hikoso S, Yamaguchi O, Nakano Y, Takeda T, Omiya S, Mizote I, Taneike M, Oka T, Tamai T, Oyabu J, Uno Y, Matsumura Y, Nishida K, Suzuki K, Kogo M, Hori M, Otsu K. The IKB kinase {beta}/nuclear factor KB signaling pathway protects the heart from hemodynamic stress mediated by the regulation of manganese superoxide dismutase expression. Circ Res. 2009;105:70-79.
13. Li QH, Guo YR, Tan W, Ou QH, Wu WJ, Sturza D, Dawn B, Hunt G, Cui C, Bolli R. Cardioprotection afforded by inducible nitric oxide synthase gene therapy is mediated by cyclooxygenase-2 via a nuclear factor-kappa B-dependent pathway. Circulation. 2007;116:1577-1584.
14. Mustapha S, Kirshner A, De Moissac D, Kirshenbaum LA. A direct requirement of nuclear factor-kappa B for suppression of apoptosis in ventricular myocytes. Am J Physiol Heart Circ Physiol. 2000;279: H939-H945.
15. Gupta S, Young D, Maitra RK, Gupta A, Popovic ZB, Yong SL, Mahajan A, Wang Q, Sen S. Prevention of cardiac hypertrophy and heart failure by silencing of NF-kappa B. J Mol Biol. 2008;375:637-649.
16. Young D, Popovic ZB, Jones WK, Gupta S. Blockade of NF-kappa B using I kappa B alpha dominant-negative mice ameliorates cardiac hypertrophy in myotrophin-overexpressed transgenic mice. J Mol Biol. 2008;381:559-568.
17. Wu SJ, Yin R, Ernest R, Li YQ, Zhelyabovska O, Luo JW, Yang YF, Yang QL. Liver X receptors are negative regulators of cardiac hypertrophy via suppressing NF-kappa B signalling. Cardiovasc Res. 2009;84: 119-126.
18. Trescher K, Bernecker O, Fellner B, Gyongyosi M, Schafer R, Aharinejad S, DeMartin R, Wolner E, Podesser BK. Inflammation and postinfarct remodeling: overexpression of IKB prevents ventricular dilation via increasing TIMP levels. Cardiovasc Res. 2006;69:746-754.
19. Hedhli N, Lizano P, Hong C, Fritzky LF, Dhar SK, Liu H, Tian Y, Gao S, Madura K, Vatner SF, Depre C. Proteasome inhibition decreases cardiac remodeling after initiation of pressure overload. Am J Physiol Heart Circ Physiol. 2008;295:H1385-H1393.
20. Wang ZB, Castresana MR, Detmer K, Newman WH. An I kappa B-alpha mutant inhibits cytokine gene expression and proliferation in human vascular smooth muscle cells. J Surg Res. 2002;102:198-206.
21. Naga Prasad SV, Duan ZH, Gupta MK, Surampudi VS, Volinia S, Calin GA, Liu CG, Kotwal A, Moravec CS, Starling RC, Perez DM, Sen S, Wu Q, Plow EF, Croce CM, Karnik S. Unique microRNA profile in end-stage heart failure indicates alterations in specific cardiovascular signaling networks. J Biol Chem. 2009;284:27487-27499.
22. Brown M, McGuinness M, Wright T, Ren X, Wang Y, Boivin GP, Hahn H, Feldman AM, Jones WK. Cardiac-specific blockade of NF-kappaB in cardiac pathophysiology: differences between acute and chronic stimuli in vivo. Am J Physiol Heart Circ Physiol. 2005;289:H466-H476.
23. Misra A, Haudek SB, Knuefermann P, Vallejo JG, Chen ZJ, Michael LH, Sivasubramanian N, Olson EN, Entman ML, Mann DL. Nuclear factor-kappaB protects the adult cardiac myocyte against ischemia-induced apoptosis in a murine model of acute myocardial infarction. Circulation. 2003;108:3075-3078.
24. Kratsios P, Huth M, Al Banchaabouchi M, Sgoifo A, Manghi M, Salimova E, Suzuki K, Rosenthal N, Mourkioti F. Antioxidant amelioration of dilated cardiomyopathy caused by conditional deletion of NEMO/IKKy in cardiomyocytes. Circ Res. 2010;106:133-144.
25. Sano M, Minamino T, Toko H, Miyauchi H, Orimo M, Qin YJ, Akazawa H, Tateno K, Kayama Y, Harada M, Shimizu I, Asahara T, Hamada H, Tomita S, Molkentin JD, Zou YZ, Komuro I. p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload. Nature. 2007; 446:444-448.
26. Chiu YH, Zhao M, Chen ZJ. Ubiquitin in NF-kappa B signaling. Chem Rev. 2009;109:1549-1560.
27. Tokunaga F, Sakata S, Saeki Y, Satomi Y, Kirisako T, Kamei K, Nakagawa T, Kato M, Murata S, Yamaoka S, Yamamoto M, Akira S, Takao T, Tanaka K, Iwai K. Involvement of linear polyubiquitylation of NEMO in NF-kappa B activation. Nat Cell Biol. 2009;11:U123-U140.
28. Laplantine E, Fontan E, Chiaravalli J, Lopez T, Lakisic G, Veron M, Agou F, Israel A. NEMO specifically recognizes K63-linked poly-ubiquitin chains through a new bipartite ubiquitin-binding domain. EMBO J. 2009;28:2885-2895.
29. Iwai K, Tokunaga F. Linear polyubiquitination: a new regulator of NF-kappa B activation. EMBO Rep. 2009;10:706-713.
30. Newton K, Matsumoto ML, Wertz IE, Kirkpatrick DS, Lill JR, Tan J, Dugger D, Gordon N, Sidhu SS, Fellouse FA, Komuves L, French DM, Ferrando RE, Lam C, Compaan D, Yu C, Bosanac I, Hymowitz SG, Kelley RF, Dixit VM. Ubiquitin chain editing revealed by polyubiquitin linkage-specific antibodies. Cell. 2008;134:668-678.
31. Verma UN, Yamamoto Y, Prajapati S, Gaynor RB. Nuclear role of I kappa B Kinase-gamma/NF-kappa B essential modulator (IKK gam-ma/NEMO) in NF-kappa B-dependent gene expression. J Biol Chem. 2004;279:3509-3515.
32. Bracken CP, Whitelaw ML, Peet DJ. Activity of hypoxia-inducible factor 2 alpha is regulated by association with the NF-kappa B essential modulator. J Biol Chem. 2005;280:14240-14251.
33. Legarda-Addison D, Hase H, O'Donnell MA, Ting AT. NEMO/IKK gamma regulates an early NF-kappa B-independent cell-death checkpoint during TNF signaling. Cell Death Differ. 2009;16:1279-1288.